2370-12-9Relevant articles and documents
MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS
-
Paragraph 00681, (2017/08/01)
Provided herein are antibacterial compounds, wherein the compounds in some embodiments have broad spectrum bioactivity. In various embodiments, the compounds act by inhibition of bacterial type 1 signal peptidase (SpsB), an essential protein in bacteria. Pharmaceutical compositions and methods for treatment using the compounds described herein are also provided.
Conformational Analysis and Stereodynamics of Primary Acyclic Alkyl Radicals by EPR Spectroscopy
Ingold, K. U.,Nonhebel, D. C.,Walton, J. C.
, p. 2859 - 2869 (2007/10/02)
The EPR spectra of n-alkyl, 2-methylalkyl, 2,2-dimethylalkyl, 2,2,3-trimethylbutyl, and 2,2,3,3-tetramethylbutyl radicals indicate that at 90 K they exist in "rigid" conformations with respect to rotation about the Cβ-Cγ bonds.The preferred conformations about the Cα-Cβ and Cβ-Cγ bonds were deduced by analysis of the β- and γ-H hyperfine splittings (hfs). 2,2,3,3-Tetramethylbutyl radicals, the only radicals with a CH3 group approximately all-trans with respect to the semioccupied p-orbital, were also the only radicals to show resolved δ-hfs.The barriers to internal rotation of the methyl groups in n-propyl, isobutyl, neopentyl, 2,2-bis(trideuteriomethyl)butyl, and 2,2,3,3-tetramethylbutyl radicals were obtained by line shape analysis; the ethyl rotation barrier in 2,2-bis(trideuteriomethyl)butyl and the tert-butyl rotation barrier in 2,2,3,3-tetramethylbutyl radicals were estimated in a similar way.The experimental hfs of trans γ-hydrogens were shown to fit a relationship of the form aHγ = 0.1 +7.9 cos2 Φ, where Φ is the dihedral angle between the SOMO and the plane through Cα, Cβ, and Cγ.Trends in the internal rotation barriers of the alkyl groups were adequately accounted for in terms of steric effects.
Preparation of 15-deoxy-16-hydroxyprostaglandins
-
, (2008/06/13)
Analogues of PGE1 having the structural formula, STR1 in which J is R-hydroxymethylene or S-hydroxymethylene; R1 is hydrogen; R2 is hydrogen or together with R4 is a methylene chain of 2 to 3 carbon atoms such that a cycloalkyl of 5 to 6 carbon atoms inclusive is formed; R3 is hydrogen or methyl, or together with R4 is a methylene or a lower alkylated methylene chain of 2 to 5 carbon atoms such that a cycloalkyl or a lower alkylated cycloalkyl of 4 to 7 carbon atoms inclusive is formed, or together with R4 is bicycloalkyl or bicycloalkenyl moiety having the formula: STR2 SUCH THAT A BICYCLOALKYL OR BICYCLOALKENYL COMPOUND IS FORMED, WHEREIN M AND N ARE INTEGERS HAVING A VALUE FROM 0 TO 3, P IS AN INTEGER HAVING A VALUE FROM 0 TO 4 AND Q IS AN INTEGER HAVING A VALUE OF FROM 1 TO 4 AND WHEREIN THE DOUBLE BOND OF SUCH BICYCLOALKENYL IS IN THE M, N, P, OR Q BRIDGE; R4 is hydrogen or methyl or together with R2 or R3 forms a cycloalkyl or bicycloalkyl or bicycloalkenyl as defined above, or together with R5 is a methylene chain of 3 to 5 carbon atoms such that a cycloalkyl of 4 to 6 carbon atoms inclusive is formed; R5 is selected from the group consisting of hydrogen, straight-chain alkyl having from 1 to 3 carbon atoms or together with R4 forms a cycloalkyl as defined above; and R6 is hydrogen or straight-chain alkyl having from 1 to 3 carbon atoms are disclosed. Pge1 ester analogues of the above formula, limited to the structures wherein two of R2, R3 R4 and R5 form a cycloalkyl, lower alkylated cycloalkyl, bicycloalkyl or bicycloalkenyl are also disclosed. The prostaglandin analogues selectively produce bronchodilation and decrease gastric secretion in vivo. Methods of preparing the analogues and starting materials required in the synthesis of the analogues are also disclosed.
